Building Blocks

<p>Versatile small molecule scaffold</p>

<p>2-Carbamoyl-2,2-dimethylacetic acid (CDCA) is a modulator of peroxisomes that belongs to the class of peroxisome proliferators. It is a lipid soluble molecule with an ability to cross the cell membrane and interact with the peroxisome. CDCA has been shown to activate peroxisomal β-oxidation, which is responsible for removing fatty acids from cells. CDCA also inhibits fatty acid synthesis in liver cells, leading to increased levels of triglycerides in the blood. CDCA belongs to one of three major families of compounds that are used as peroxisome proliferators: phthalates and di(2-ethylhexyl)phthalate (DEHP), dibutylphthalate (DBP), and benzophenones.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Azido-4-bromobutane is a synthetic molecule that can be used to stabilize glycoconjugates. It has been shown to have the ability to inhibit cell proliferation in vitro and in vivo. 1-Azido-4-bromobutane has been shown to induce apoptosis and inhibit tumor growth. The compound also has a high affinity for DNA and can bind to intercalators, which are small molecules that bind to DNA base pairs within the double helix. This property can be used as a diagnostic marker for cancer cells or as an anticancer agent.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)pent-4-ynoic acid is a synthetic amino acid that has been used to study bacterial resistance. The molecule was synthesized by the reaction of 9H-fluorene with pentanenitrile. This organic compound is an isomer of 2,3,4,5,6-pentafluoroheptanoic acid and can be analyzed by FTIR spectroscopy. It has been used to calibrate the mass spectrometer and identify the isomerism in amino acids. The molecule also has diagnostic potential as it can be used to detect the presence of carbohydrates in a sample.<br>2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)pent-4-ynoic acid is also a protonated molecule that reacts with matrix ions</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-3-iodopyrazine is a reactive compound that can be used to synthesize diazines. This compound reacts readily with lithium metal in the presence of magnesium to form the corresponding Grignard reagent. The Grignard reagent then reacts with carbon monoxide to produce the desired diazine. 2-Chloro-3-iodopyrazine can also be converted to a functionalized heterocycle through sonication, which produces cinnoline and halogen as products.<br>2-Chloro-3-iodopyrazine is not soluble in water but will react with alcohols such as ethanol and methanol, producing chloroethanol and chloromethyl ether, respectively.</p>

<p>{4-[(2-Aminophenyl)sulfanyl]butyl}phosphonic acid is a polymerase chain reaction (PCR) reagent that is used to detect the presence of nucleic acids in solution. It is a phosphonic acid derivative that has been shown to be effective against both human and animal pathogens, such as HIV, hepatitis B and C, influenza A and B, RSV, and vaccinia virus. This compound can also be used as an inhibitor of DNA polymerases in the presence of radiation or natural compounds.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methyl-5-(trifluoromethyl)-1H-pyrrole-3-carboxylic acid is a photosynthetic compound that is also an acid complex. It has been shown to inhibit the synthesis of chlorophyll a., which is necessary for photosynthesis in plants. This compound also has the ability to chelate ligands and bind to proton, which can affect electron transfer. 2-Methyl-5-(trifluoromethyl)-1H-pyrrole-3-carboxylic acid can be found in redox potentials. The redox potential is the measure of oxidation or reduction with respect to the equilibrium between oxidized and reduced forms of a species at a particular temperature. It has also been shown to have an antiinflammatory effect on bowel disease, such as inflammatory bowel disease.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor agonist. It has been shown to have antidepressant effects in animal models of depression and is currently in clinical development for the treatment of depression. BDMOB also has anti-nociceptive activity, which may be due to its ability to inhibit the release of proinflammatory cytokines from macrophages and microglial cells. This drug also inhibits cancer cell growth and chronic pain.

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Methoxy-2-(trifluoromethyl)benzylamine (4MTA) is a benzoic acid derivative that has been shown to inhibit the activity of enzymes involved in neurotransmitter synthesis. 4MTA inhibits the activity of acetylcholinesterase and butyrylcholinesterase, which are enzymes involved in the synthesis of acetylcholine. This inhibition leads to an accumulation of acetylcholine at synapses, causing an increase in the release of this neurotransmitter. The increased release of acetylcholine leads to an increase in its binding to receptors on postsynaptic cells, causing a reduction in neuronal excitability. 4MTA is also used as a positron emission tomography (PET) tracer due to its ability to bind with high affinity to cholinergic neurons by desmethylation in vivo.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>